BIOVENTUS INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$684M
↓-6.1% -$44Mvs FY2024
Total Liabilities
$455M
↓-16.1% -$87Mvs FY2024
Equity
$184M
↑+24.4% +$36Mvs FY2024
Cash
$51M
↑+23.2% +$10Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $684M | $728M |
| Current Assets | $273M | $276M |
| Cash | $51M | $42M |
| ST Investments | $0 | $0 |
| Receivables | $128M | $127M |
| Inventory | $82M | $92M |
| Other Current | $11M | $14M |
| Non-Current Assets | $411M | $452M |
| PPE | $0 | $0 |
| Goodwill | $7M | $7M |
| Intangibles | $368M | $405M |
| Investments | $2M | $2M |
| Other Non-Current | $33M | $38M |
| Total Liab+Eq | $639M | $690M |
| Current Liab. | $160M | $210M |
| Accounts Payable | $11M | $24M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $955K | $2M |
| Other CL | $148M | $185M |
| Non-Current Liab. | $295M | $332M |
| Long-Term Debt | $279M | $308M |
| Other LT Liab. | $16M | $24M |
| Equity | $184M | $148M |
| Retained Earnings | $335M | $358M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · BVS · Comparing FY2025 vs FY2024